Open Insider Trading Activity for Avalo Therapeutics, Inc. Chief Financial Officer Sullivan Christopher Ryan
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction AVTX | 2026-09-18 | 2026-09-16 | Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 1 | 12,394 | $16.33 | $202,437.40 | 23.70% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction AVTX | 2026-05-11 | 2026-05-07 | Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 1 | 18,606 | $24.12 | $448,776.72 | 97.78% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction AVTX | 2026-05-07 | 2026-05-06 | Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 5 | 47,000 | $20.18 | $948,605.89 | 36.12% | View Filing |